Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation

References

• Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. BJOG 2006;113(Suppl 3):17–42.
   PubMed Web of Science ®Google Scholar
• Naeye RL, Ross SM. Amniotic fluid infection syndrome. Clin Obstet Gynaecol 1982;9:593–607.
   PubMed Web of Science ®Google Scholar
• Minkoff H. Prematurity: infection as an etiologic factor. Obstet Gynecol 1983;62:137–144.
   PubMed Web of Science ®Google Scholar
• Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD, Hobbins JC. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988;12:262–279.
   PubMed Web of Science ®Google Scholar
• Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988;31:553–584.
   PubMed Web of Science ®Google Scholar
• Ledger WJ. Infection and premature labor. Am J Perinatol 1989;6:234–236.
   PubMed Web of Science ®Google Scholar
• Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanassiadis AP, Hobbins JC. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989;161:817–824.
   PubMed Web of Science ®Google Scholar
• Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992;166:1515–1528.
   PubMed Web of Science ®Google Scholar
• Brocklehurst P. Infection and preterm delivery. BMJ 1999;318:548–549.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500–1507.
   PubMed Web of Science ®Google Scholar
• Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002;8:3–13.
   PubMedGoogle Scholar
• Hirsch E, Wang H. The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model. J Soc Gynecol Investig 2005;12:145–155.
   PubMedGoogle Scholar
• Yoon BH, Romero R, Moon JB, Shim SS, Kim M, Kim G, Jun JK. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001;185:1130–1136.
   PubMed Web of Science ®Google Scholar
• Kim KW, Romero R, Park HS, Park CW, Shim SS, Jun JK, Yoon BH. A rapid matrix metalloproteinase-8 bedside test for the detection of intraamniotic inflammation in women with preterm premature rupture of membranes. Am J Obstet Gynecol 2007;197:292–295.
   PubMed Web of Science ®Google Scholar
• Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186–193.
   PubMed Web of Science ®Google Scholar
• Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194–202.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Kim CJ, Jun JK, Gomez R, Choi JH, Syn HC. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 1995;172:960–970.
   PubMed Web of Science ®Google Scholar
• Dammann O and Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997;42:1–8.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825–830.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH, Kim IO. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19–26.
   PubMed Web of Science ®Google Scholar
• Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O, Kuban K, Van Marter LJ, Pagano M, Hegyi T, et al Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res 1999;46:566–575.
   Google Scholar
• Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999;181:773–779.
   PubMed Web of Science ®Google Scholar
• Dammann O, Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr 2000;12:99–104.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, Han TR. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182:675–681.
   PubMed Web of Science ®Google Scholar
• Gibbs RS. The relationship between infections and adverse pregnancy outcomes: an overview. Ann Periodontol 2001;6:153–163.
   PubMedGoogle Scholar
• Patrick LA, Smith GN. Proinflammatory cytokines: a link between chorioamnionitis and fetal brain injury. J Obstet Gynaecol Can 2002;24:705–709.
   PubMedGoogle Scholar
• Yoon BH, Romero R, Shim JY, Lim JH, Choe G, Kadar N, Park M. ‘Atypical’ chronic lung disease of the newborn is linked to fetal systemic inflammation. Am J Obstet Gynecol 2002;187:S129.
   Google Scholar
• Yoon BH, Park CW, Chaiworapongsa T. Intrauterine infection and the development of cerebral palsy. BJOG 2003;110(Suppl 20):124–127.
   PubMed Web of Science ®Google Scholar
• Hagberg H, Mallard C, Jacobsson B. Role of cytokines in preterm labour and brain injury. BJOG 2005;112(Suppl 1):16–18.
   PubMedGoogle Scholar
• Bashiri A, Burstein E, Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med 2006;34:5–12.
   PubMed Web of Science ®Google Scholar
• Iams JD, Johnson FF, Sonek J, Sachs L, Gebauer C, Samuels P. Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance. Am J Obstet Gynecol 1995;172:1097–1103.
   PubMed Web of Science ®Google Scholar
• Romero R, Espinoza J, Erez O, Hassan S. The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified? Am J Obstet Gynecol 2006;194:1–9.
   PubMed Web of Science ®Google Scholar
• Phelan JP, Park YW, Ahn MO, Rutherford SE. Polyhydramnios and perinatal outcome. J Perinatol 1990;10:347–350.
   PubMedGoogle Scholar
• Romero R, Mazor M, Avila C, Quintero R, Munoz H. Uterine ‘allergy’: a novel mechanism for preterm labor. Am J Obstet Gynecol 1991;164:375.
   Google Scholar
• Garfield RE, Bytautiene E, Vedernikov YP, Marshall JS, Romero R. Modulation of rat uterine contractility by mast cells and their mediators. Am J Obstet Gynecol 2000;183:118–125.
   PubMed Web of Science ®Google Scholar
• Bytautiene E, Vedernikov YP, Saade GR, Romero R, Garfield RE. Endogenous mast cell degranulation modulates cervical contractility in the guinea pig. Am J Obstet Gynecol 2002;186:438–445.
   PubMedGoogle Scholar
• Bytautiene E, Romero R, Vedernikov YP, El-Zeky F, Saade GR, Garfield RE. Induction of premature labor and delivery by allergic reaction and prevention by histamine H1 receptor antagonist. Am J Obstet Gynecol 2004;191:1356–1361.
   PubMed Web of Science ®Google Scholar
• Csapo AI, Pohanka O, Kaihola HL. Progesterone deficiency and premature labour. Br Med J 1974;1:137–140.
   PubMedGoogle Scholar
• Check JH, Lee G, Epstein R, Vetter B. Increased rate of preterm deliveries in untreated women with luteal phase deficiencies. Preliminary report. Gynecol Obstet Invest 1992;33:183–184.
   PubMed Web of Science ®Google Scholar
• Mazor M, Hershkovitz R, Chaim W, Levy J, Sharony Y, Leiberman JR, Glezerman M. Human preterm birth is associated with systemic and local changes in progesterone/17 beta-estradiol ratios. Am J Obstet Gynecol 1994;171:231–236.
   PubMedGoogle Scholar
• Fidel PI Jr., Romero R, Maymon E, Hertelendy F. Bacteria-induced or bacterial product-induced preterm parturition in mice and rabbits is preceded by a significant fall in serum progesterone concentrations. J Matern Fetal Med 1998;7:222–226.
   PubMedGoogle Scholar
• Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993;168:585–591.
   PubMed Web of Science ®Google Scholar
• Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 1997;89:265–271.
   PubMed Web of Science ®Google Scholar
• Kim YM, Chaiworapongsa T, Gomez R, Bujold E, Yoon BH, Rotmensch S, Thaler HT, Romero R. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002;187:1137–1142.
   PubMed Web of Science ®Google Scholar
• Kim YM, Bujold E, Chaiworapongsa T, Gomez R, Yoon BH, Thaler HT, Rotmensch S, Romero R. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2003;189:1063–1069.
   PubMed Web of Science ®Google Scholar
• Romero R, Sepulveda W, Baumann P, Yoon BH, Brandt F, Gomez R, Mazor M, Sorokin Y, Cotton D. The preterm labor syndrome: biochemical, cytologic, immunologic, pathologic, microbiologic, and clinical evidence that preterm labor is a heterogeneous disease. Am J Obstet Gynecol 1993;168:288.
   Google Scholar
• Kilpatrick DC. Immune mechanisms and pre-eclampsia. Lancet 1987;2:1460–1461.
   PubMedGoogle Scholar
• McLean JM. Early embryo loss. Lancet 1987;1:1033–1034.
   PubMedGoogle Scholar
• Aksel S. Immunologic aspects of reproductive diseases. JAMA 1992;268:2930–2934.
   PubMedGoogle Scholar
• Schmidt CM and Orr HT. A physical linkage map of HLA-A, -G, -7.5p, and -F. Hum Immunol 1991;31:180–185.
   PubMedGoogle Scholar
• Carosella ED, Favier B, Rouas-Freiss N, Moreau P, LeMaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008;111:4862–4870.
   PubMed Web of Science ®Google Scholar
• Hunt JS, Pace JL, Morales PJ, Ober C. Immunogenicity of the soluble isoforms of HLA-G. Mol Hum Reprod 2003;9:729–735.
   PubMed Web of Science ®Google Scholar
• Sargent IL. Does ‘soluble’ HLA-G really exist? Another twist to the tale. Mol Hum Reprod 2005;11:695–698.
   PubMedGoogle Scholar
• Pace JL, Morales PJ, Phillips TA, Hunt JS. Analysis of the soluble isoforms of HLA-G mRNAs and proteins. Methods Mol Med 2006;122:181–203.
   PubMedGoogle Scholar
• Rebmann V, LeMaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H. Quantification and identification of soluble HLA-G isoforms. Tissue Antigens 2007;69(Suppl 1):143–149.
   PubMedGoogle Scholar
• Ishitani A and Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 1992;89:3947–3951.
   PubMed Web of Science ®Google Scholar
• Carosella ED, Moreau P, Le MJ, Le DM, Dausset J, Rouas-Freiss N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003;81:199–252.
   PubMed Web of Science ®Google Scholar
• Alegre E, az-Lagares A, LeMaoult J, Lopez-Moratalla N, Carosella ED, Gonzalez A. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy. Hum Immunol 2007;68:661–667.
   PubMedGoogle Scholar
• Yelavarthi KK, Fishback JL, Hunt JS. Analysis of HLA-G mRNA in human placental and extraplacental membrane cells by in situ hybridization. J Immunol 1991;146:2847–2854.
   PubMed Web of Science ®Google Scholar
• Chu W, Fant ME, Geraghty DE, Hunt JS. Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon-gamma-activated macrophages but not placental fibroblasts. Hum Immunol 1998;59:435–442.
   PubMedGoogle Scholar
• Le Bouteiller P, Solier C, Proll J, guerre-Girr M, Fournel S, Lenfant F. Placental HLA-G protein expression in vivo: where and what for? Hum Reprod Update 1999;5:223–233.
   PubMed Web of Science ®Google Scholar
• Le Bouteiller P. HLA-G in the human placenta: expression and potential functions. Biochem Soc Trans 2000;28:208–212.
   PubMed Web of Science ®Google Scholar
• Morales PJ, Pace JL, Platt JS, Phillips TA, Morgan K, Fazleabas AT, Hunt JS. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol 2003;171:6215–6224.
   PubMed Web of Science ®Google Scholar
• Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet JG, Carosella ED, Rouas-Freiss N. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 1999;11:1351–1356.
   PubMed Web of Science ®Google Scholar
• Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J. 2005;19:681–693.
   PubMed Web of Science ®Google Scholar
• Hackmon R, Koifman A, Hyodo H, Glickman H, Sheiner E, Geraghty DE. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol 2007;197:255.
   PubMedGoogle Scholar
• Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse-Wilde H. Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancy. Am J Obstet Gynecol 2003;188:473–479.
   PubMedGoogle Scholar
• Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse-Wilde H. Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G. J Clin Immunol 2003;23:307–314.
   PubMedGoogle Scholar
• Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol 2007;57:277–286.
   PubMed Web of Science ®Google Scholar
• Carosella ED, Moreau P, LeMaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008;29:125–132.
   PubMed Web of Science ®Google Scholar
• Monneret G, Voirin N, Krawice-Radanne I, Bohe J, Lepape A, Rouas-Freiss N, Carosella ED. Soluble human leukocyte antigen-G5 in septic shock: marked and persisting elevation as a predictor of survival. Crit Care Med 2007;35:1942–1947.
   PubMedGoogle Scholar
• McMaster M, Zhou Y, Shorter S, Kapasi K, Geraghty D, Lim KH, Fisher S. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J Immunol 1998;160:5922–5928.
   PubMedGoogle Scholar
• Puppo F, Costa M, Contini P, Brenci S, Cevasco E, Ghio M, Norelli R, Bensussan A, Capitanio GL, Indiveri F. Determination of soluble HLA-G and HLA-A, -B, and -C molecules in pregnancy. Transplant Proc 1999;31:1841–1843.
   PubMedGoogle Scholar
• Rebmann V, Pfeiffer K, Passler M, Ferrone S, Maier S, Weiss E, Grosse-Wilde H. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999;53:14–22.
   PubMed Web of Science ®Google Scholar
• Emmer PM, Steegers EA, van Lierop MJ, Loke YW, van der MA, Joosten I. Levels of soluble HLA-G in amniotic fluid are related to the sex of the offspring. Eur J Immunogenet 2003;30:163–164.
   PubMedGoogle Scholar
• Hackmon R, Hallak M, Krup M, Weitzman D, Sheiner E, Kaplan B, Weinstein Y. HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy. Fetal Diagn Ther 2004;19:404–409.
   PubMed Web of Science ®Google Scholar
• Kusanovic JP, Romero R, Mazaki-Tovi S, Chaiworapongsa T, Mittal P, Gotsch F, Erez O, Vaisbuch E, Edwin SS, Than NG, et al Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation. J Matern Fetal Neonatal Med 2008;21:902–916.
   PubMed Web of Science ®Google Scholar
• Pacora P, Chaiworapongsa T, Maymon E, Kim YM, Gomez R, Yoon BH, Ghezzi F, Berry SM, Qureshi F, Jacques SM, et al Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002;11:18–25.
   PubMedGoogle Scholar
• Romero R, Emamian M, Quintero R, Wan M, Hobbins JC, Mazor M, Edberg S. The value and limitations of the Gram stain examination in the diagnosis of intraamniotic infection. Am J Obstet Gynecol 1988;159:114–119.
   PubMed Web of Science ®Google Scholar
• Romero R, Jimenez C, Lohda AK, Nores J, Hanaoka S, Avila C, Callahan R, Mazor M, Hobbins JC, Diamond MP. Amniotic fluid glucose concentration: a rapid and simple method for the detection of intraamniotic infection in preterm labor. Am J Obstet Gynecol 1990;163:968–974.
   PubMed Web of Science ®Google Scholar
• Romero R, Quintero R, Nores J, Avila C, Mazor M, Hanaoka S, Hagay Z, Merchant L, Hobbins JC. Amniotic fluid white blood cell count: a rapid and simple test to diagnose microbial invasion of the amniotic cavity and predict preterm delivery. Am J Obstet Gynecol 1991;165:821–830.
   PubMed Web of Science ®Google Scholar
• Bonferroni C. Il calcolo delle assicurazioni su gruppi di teste. 1935; 13–60.
   Google Scholar
• Geraghty DE, Koller BH, Orr HT. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA 1987;84:9145–9149.
   PubMed Web of Science ®Google Scholar
• Parham P, Lomen CE, Lawlor DA, Ways JP, Holmes N, Coppin HL, Salter RD, Wan AM, Ennis PD. Nature of polymorphism in HLA-A, -B, and -C molecules. Proc Natl Acad Sci USA 1988;85:4005–4009.
   PubMed Web of Science ®Google Scholar
• Schmidt CM and Orr HT. Maternal/fetal interactions: the role of the MHC class I molecule HLA-G. Crit Rev Immunol 1993;13:207–224.
   PubMed Web of Science ®Google Scholar
• Carosella ED, Dausset J, Kirszenbaum M. HLA-G revisited. Immunol Today 1996;17:407–409.
   PubMedGoogle Scholar
• van der Ven K, Ober C. HLA-G polymorphisms in African Americans. J Immunol 1994;153:5628–5633.
   PubMed Web of Science ®Google Scholar
• Ober C, Rosinsky B, Grimsley C, van der VK, Robertson A, Runge A. Population genetic studies of HLA-G: allele frequencies and linkage disequilibrium with HLA-A1. J Reprod Immunol 1996;32:111–123.
   PubMedGoogle Scholar
• Ober C and Aldrich CL. HLA-G polymorphisms: neutral evolution or novel function? J Reprod Immunol 1997;36:1–21.
   PubMedGoogle Scholar
• van der Ven K, Skrablin S, Ober C, Krebs D. HLA-G polymorphisms: ethnic differences and implications for potential molecule function. Am J Reprod Immunol 1998;40:145–157.
   PubMedGoogle Scholar
• Ellis SA, Palmer MS, McMichael AJ. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. J Immunol 1990;144:731–735.
   PubMed Web of Science ®Google Scholar
• Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen HLA-G, expressed in human trophoblasts. Science 1990;248:220–223.
   PubMed Web of Science ®Google Scholar
• Koller BH, Geraghty DE, DeMars R, Duvick L, Rich SS, Orr HT. Chromosomal organization of the human major histocompatibility complex class I gene family. J Exp Med 1989;169:469–480.
   PubMedGoogle Scholar
• Favier B, LeMaoult J, Carosella ED. Functions of HLA-G in the immune system. Tissue Antigens 2007;69(Suppl 1):150–152.
   PubMedGoogle Scholar
• Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997;186:1809–1818.
   PubMed Web of Science ®Google Scholar
• Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997;7:273–282.
   PubMed Web of Science ®Google Scholar
• Saverino D, Fabbi M, Ghiotto F, Merlo A, Bruno S, Zarcone D, Tenca C, Tiso M, Santoro G, Anastasi G, et al The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J Immunol 2000;165:3742–3755.
   PubMed Web of Science ®Google Scholar
• Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, Dunbar R, Ogg GS, Cerundolo V, Rolink A. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998;160:3096–3100.
   PubMed Web of Science ®Google Scholar
• Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vitale C, Bertone S, Moretta A, Moretta L, Mingari MC. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA 1999;96:5674–5679.
   PubMed Web of Science ®Google Scholar
• Rajagopalan S and Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999;189:1093–1100.
   PubMed Web of Science ®Google Scholar
• King A, Boocock C, Sharkey AM, Gardner L, Beretta A, Siccardi AG, Loke YW. Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. J Immunol 1996;156:2068–2076.
   PubMedGoogle Scholar
• Yang Y, Chu W, Geraghty DE, Hunt JS. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J Immunol 1996;156:4224–4231.
   PubMed Web of Science ®Google Scholar
• Blaschitz A, Lenfant F, Mallet V, Hartmann M, Bensussan A, Geraghty DE, Le BP, Dohr G. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol 1997;27:3380–3388.
   PubMed Web of Science ®Google Scholar
• Rabreau M, Rouas-Freiss N, Landi M, Le DC, Carosella ED. HLA-G expression in trophoblast cells is independent of embryonic development. Hum Immunol 2000;61:1108–1112.
   PubMed Web of Science ®Google Scholar
• Mallet V, Fournel S, Schmitt C, Campan A, Lenfant F, Le BP. Primary cultured human thymic epithelial cells express both membrane-bound and soluble HLA-G translated products. J Reprod Immunol 1999;43:225–234.
   PubMedGoogle Scholar
• Le Discorde M, Moreau P, Sabatier P, Legeais JM, Carosella ED. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 2003;64:1039–1044.
   PubMed Web of Science ®Google Scholar
• Cirulli V, Zalatan J, McMaster M, Prinsen R, Salomon DR, Ricordi C, Torbett BE, Meda P, Crisa L. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 2006;55:1214–1222.
   PubMed Web of Science ®Google Scholar
• Menier C, Rabreau M, Challier JC, Le DM, Carosella ED, Rouas-Freiss N. Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 2004;104:3153–3160.
   PubMed Web of Science ®Google Scholar
• Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG, Carosella ED. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 1998;95:4510–4515.
   PubMed Web of Science ®Google Scholar
• Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Cancer Res 2005;65:10139–10144.
   PubMed Web of Science ®Google Scholar
• Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000;355:2138.
   PubMedGoogle Scholar
• Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, et al Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain 2005;128:2689–2704.
   PubMed Web of Science ®Google Scholar
• Aractingi S, Briand N, Le DC, Viguier M, Bachelez H, Michel L, Dubertret L, Carosella ED. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol 2001;159:71–77.
   PubMedGoogle Scholar
• Khosrotehrani K, Le DC, Reynaud-Mendel B, Dubertret L, Carosella ED, Aractingi S. HLA-G expression in atopic dermatitis. J Invest Dermatol 2001;117:750–752.
   PubMedGoogle Scholar
• Lozano JM, Gonzalez R, Kindelan JM, Rouas-Freiss N, Caballos R, Dausset J, Carosella ED, Pena J. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002;16:347–351.
   PubMedGoogle Scholar
• Lafon M, Prehaud C, Megret F, Lafage M, Mouillot G, Roa M, Moreau P, Rouas-Freiss N, Carosella ED. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 2005;79:15226–15237.
   PubMed Web of Science ®Google Scholar
• Shukla H, Swaroop A, Srivastava R, Weissman SM. The mRNA of a human class I gene HLA G/HLA 6.0 exhibits a restricted pattern of expression. Nucleic Acids Res 1990;18:2189.
   PubMedGoogle Scholar
• Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 1997;186:289–298.
   PubMed Web of Science ®Google Scholar
• Houlihan JM, Biro PA, Fergar-Payne A, Simpson KL, Holmes CH. Evidence for the expression of non-HLA-A,-B,-C class I genes in the human fetal liver. J Immunol 1992;149:668–675.
   PubMed Web of Science ®Google Scholar
• Onno M, Guillaudeux T, Amiot L, Renard I, Drenou B, Hirel B, Girr M, Semana G, Le BP, Fauchet R. The HLA-G gene is expressed at a low mRNA level in different human cells and tissues. Hum Immunol 1994;41:79–86.
   PubMedGoogle Scholar
• Ulbrecht M, Rehberger B, Strobel I, Messer G, Kind P, Degitz K, Bieber T, Weiss EH. HLA-G: expression in human keratinocytes in vitro and in human skin in vivo. Eur J Immunol 1994;24:176–180.
   PubMedGoogle Scholar
• Chumbley G, King A, Gardner L, Howlett S, Holmes N, Loke YW. Generation of an antibody to HLA-G in transgenic mice and demonstration of the tissue reactivity of this antibody. J Reprod Immunol 1994;27:173–186.
   PubMedGoogle Scholar
• Hammer A, Hutter H, Dohr G. HLA class I expression on the materno-fetal interface. Am J Reprod Immunol 1997;38:150–157.
   PubMed Web of Science ®Google Scholar
• Lanier LL. Natural killer cells fertile with receptors for HLA-G? Proc Natl Acad Sci USA 1999;96:5343–5345.
   PubMed Web of Science ®Google Scholar
• Hunt JS, Petroff MG, Morales P, Sedlmayr P, Geraghty DE, Ober C. HLA-G in reproduction: studies on the maternal-fetal interface. Hum Immunol 2000;61:1113–1117.
   PubMedGoogle Scholar
• Hviid TV. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update 2006;12:209–232.
   PubMed Web of Science ®Google Scholar
• Hunt JS, Orr HT. HLA and maternal–fetal recognition. FASEB J 1992;6:2344–2348.
   PubMed Web of Science ®Google Scholar
• Ober C, van der VK. Immunogenetics of reproduction: an overview. Curr Top Microbiol Immunol 1997;222:1–23.
   PubMed Web of Science ®Google Scholar
• Ober C. HLA and pregnancy: the paradox of the fetal allograft. Am J Hum Genet 1998;62:1–5.
   PubMed Web of Science ®Google Scholar
• Moreau P, Paul P, Rouas-Freiss N, Kirszenbaum M, Dausset J, Carosella ED. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft. Am J Reprod Immunol 1998;40:136–144.
   PubMedGoogle Scholar
• Rouas-Freiss N, Khalil-Daher I, Marchal-Bras GR, Menier C, Dausset J, Carosella ED. Role of HLA-G in maternal-fetal immune tolerance. Transplant Proc 1999;31:724–725.
   PubMedGoogle Scholar
• Hunt JS. Stranger in a strange land. Immunol Rev 2006;213:36–47.
   PubMed Web of Science ®Google Scholar
• Hunt JS, Langat DK, McIntire RH, Morales PJ. The role of HLA-G in human pregnancy. Reprod Biol Endocrinol 2006;4(Suppl 1):S10.
   PubMedGoogle Scholar
• Pazmany L, Mandelboim O, Vales-Gomez M, Davis DM, Reyburn HT, Strominger JL. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996;274:792–795.
   PubMed Web of Science ®Google Scholar
• Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997;94:11520–11525.
   PubMed Web of Science ®Google Scholar
• Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 1997;94:5249–5254.
   PubMed Web of Science ®Google Scholar
• Marchal-Bras-Goncalves R, Rouas-Freiss N, Connan F, Choppin J, Dausset J, Carosella ED, Kirszenbaum M, Guillet J. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc 2001;33:2355–2359.
   PubMedGoogle Scholar
• Riteau B, Menier C, Khalil-Daher I, Sedlik C, Dausset J, Rouas-Freiss N, Carosella ED. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999;43:203–211.
   PubMedGoogle Scholar
• Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 2001;98:12150–12155.
   PubMed Web of Science ®Google Scholar
• LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 2004;101:7064–7069.
   PubMedGoogle Scholar
• Le Rond S, Azema C, Krawice-Radanne I, Durrbach A, Guettier C, Carosella ED, Rouas-Freiss N. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells. J Immunol 2006;176:3266–3276.
   PubMed Web of Science ®Google Scholar
• Fournel S, guerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A, Bensussan A, Le BP. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000;164:6100–6104.
   PubMed Web of Science ®Google Scholar
• Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003;33:125–134.
   PubMed Web of Science ®Google Scholar
• Feger U, Tolosa E, Huang YH, Waschbisch A, Biedermann T, Melms A, Wiendl H. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 2007;110:568–577.
   PubMed Web of Science ®Google Scholar
• Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, Chung-Bang H, Ng SC, Beaman KD, Mantouvalos HP, Beer AE. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001;16:855–861.
   PubMed Web of Science ®Google Scholar
• Coulam CB, Roussev RG. Increasing circulating T-cell activation markers are linked to subsequent implantation failure after transfer of in vitro fertilized embryos. Am J Reprod Immunol 2003;50:340–345.
   PubMedGoogle Scholar
• Petroff MG, Sedlmayr P, Azzola D, Hunt JS. Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules. J Reprod Immunol 2002;56:3–17.
   PubMed Web of Science ®Google Scholar
• Hunt JS, Jadhav L, Chu W, Geraghty DE, Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000;183:682–688.
   PubMed Web of Science ®Google Scholar
• Athanassakis I, Paflis M, Ranella A, Vassiliadis S. Detection of soluble HLA-G levels in maternal serum can be predictive for a successful pregnancy. Transplant Proc 1999;31:1834–1837.
   PubMedGoogle Scholar
• Rudstein-Svetlicky N, Loewenthal R, Horejsi V, Gazit E. HLA-G levels in serum and plasma. Tissue Antigens 2006;67:111–116.
   PubMedGoogle Scholar
• Balasch J, Jove I, Martorell J, Gaye A, Vanrell JA. Histocompatibility in in vitro fertilization couples. Fertil Steril 1993;59:456–458.
   PubMedGoogle Scholar
• Ober C, Aldrich C, Rosinsky B, Robertson A, Walker MA, Willadsen S, Verp MS, Geraghty DE, Hunt JS. HLA-G1 protein expression is not essential for fetal survival. Placenta 1998;19:127–132.
   PubMed Web of Science ®Google Scholar
• Pfeiffer KA, Rebmann V, Passler M, van der VK, van der VH, Krebs D, Grosse-Wilde H. Soluble HLA levels in early pregnancy after in vitro fertilization. Hum Immunol 2000;61:559–564.
   PubMedGoogle Scholar
• Aldrich CL, Stephenson MD, Karrison T, Odem RR, Branch DW, Scott JR, Schreiber JR, Ober C. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod 2001;7:1167–1172.
   PubMedGoogle Scholar
• Pfeiffer KA, Fimmers R, Engels G, van der VK, van der VH. The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol Hum Reprod 2001;7:373–378.
   PubMed Web of Science ®Google Scholar
• Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 2002;60:122–132.
   PubMed Web of Science ®Google Scholar
• Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, Bencini E, Menicucci A, Baricordi OR. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002;32:311–315.
   PubMedGoogle Scholar
• Ober C, Aldrich CL, Chervoneva I, Billstrand C, Rahimov F, Gray HL, Hyslop T. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003;72:1425–1435.
   PubMed Web of Science ®Google Scholar
• Sher G, Keskintepe L, Nouriani M, Roussev R, Batzofin J. Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of ‘embryo competency’ and IVF outcome. Reprod Biomed Online 2004;9:74–78.
   PubMed Web of Science ®Google Scholar
• Abbas A, Tripathi P, Naik S, Agrawal S. Analysis of human leukocyte antigen (HLA)-G polymorphism in normal women and in women with recurrent spontaneous abortions. Eur J Immunogenet 2004;31:275–278.
   PubMedGoogle Scholar
• Yao YQ, Barlow DH, Sargent IL. Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. J Immunol 2005;175:8379–8385.
   PubMedGoogle Scholar
• Noci I, Fuzzi B, Rizzo R, Melchiorri L, Criscuoli L, Dabizzi S, Biagiotti R, Pellegrini S, Menicucci A, Baricordi OR. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod 2005;20:138–146.
   PubMed Web of Science ®Google Scholar
• Sher G, Keskintepe L, Batzofin J, Fisch J, Acacio B, Ahlering P, Ginsburg M. Influence of early ICSI-derived embryo sHLA-G expression on pregnancy and implantation rates: a prospective study. Hum Reprod 2005;20:1359–1363.
   PubMedGoogle Scholar
• Sher G, Keskintepe L, Fisch JD, Acacio BA, Ahlering P, Batzofin J, Ginsburg M. Soluble human leukocyte antigen G expression in phase I culture media at 46 hours after fertilization predicts pregnancy and implantation from day 3 embryo transfer. Fertil Steril 2005;83:1410–1413.
   PubMedGoogle Scholar
• Bhalla A, Stone PR, Liddell HS, Zanderigo A, Chamley LW. Comparison of the expression of human leukocyte antigen (HLA)-G and HLA-E in women with normal pregnancy and those with recurrent miscarriage. Reproduction 2006;131:583–589.
   PubMed Web of Science ®Google Scholar
• Ober C, Billstrand C, Kuldanek S, Tan Z. The miscarriage-associated HLA-G -725G allele influences transcription rates in JEG-3 cells. Hum Reprod 2006;21:1743–1748.
   PubMedGoogle Scholar
• Rebmann V, Switala M, Eue I, Schwahn E, Merzenich M, Grosse-Wilde H. Rapid evaluation of soluble HLA-G levels in supernatants of in vitro fertilized embryos. Hum Immunol 2007;68:251–258.
   PubMedGoogle Scholar
• Goldman-Wohl DS, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S, Yagel S. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 2000;6:88–95.
   PubMed Web of Science ®Google Scholar
• Le Bouteiller P, Pizzato N, Barakonyi A, Solier C. HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol 2003;59:219–234.
   PubMed Web of Science ®Google Scholar
• Hara N, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody ‘87G’ and anti-cytokeratin antibody ‘CAM5.2’. Am J Reprod Immunol 1996;36:349–358.
   PubMed Web of Science ®Google Scholar
• Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol 2004;191:525–529.
   PubMed Web of Science ®Google Scholar
• Hylenius S, Andersen AM, Melbye M, Hviid TV. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod 2004;10:237–246.
   PubMed Web of Science ®Google Scholar
• Yie SM, Taylor RN, Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 2005;193:204–208.
   PubMed Web of Science ®Google Scholar
• Datema G, van Meir CA, Kanhai HH, van den Elsen PJ. Pre-term birth and severe pre-eclampsia are not associated with altered expression of HLA on human trophoblasts. Am J Reprod Immunol 2003;49:193–201.
   PubMedGoogle Scholar
• Hviid TV. HLA-G genotype is associated with fetoplacental growth. Hum Immunol 2004;65:586–593.
   PubMed Web of Science ®Google Scholar
• Aldrich C, Verp MS, Walker MA, Ober C. A null mutation in HLA-G is not associated with preeclampsia or intrauterine growth retardation. J Reprod Immunol 2000;47:41–48.
   PubMedGoogle Scholar
• Emmer PM, Steegers EA, van Lierop MJ, Steegers-Theunissen RP, Loke YW, Joosten I. Amniotic fluid soluble human leukocyte antigen G is markedly decreased in offspring with neural tube defects. Early Hum Dev 2002;66:101–105.
   PubMedGoogle Scholar
• Houlihan JM, Biro PA, Harper HM, Jenkinson HJ, Holmes CH. The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. J Immunol 1995;154:5665–5674.
   PubMed Web of Science ®Google Scholar
• Mazzucchelli I, Avanzini MA, Ciardelli L, Pagani S, Greco R, Belloni C, Castellazzi A, Marconi M, Rondini G, Polatti F. Human amniotic fluid cells are able to produce IL-6 and IL-8. Am J Reprod Immunol 2004;51:198–203.
   PubMed Web of Science ®Google Scholar
• Yan WH, Lin A, Chen XJ, Dai MZ, Xu HH, Chen BG, Gan LH, Shi WW. Immunological aspects of human amniotic fluid cells: implication for normal pregnancy. Cell Biol Int 2008;32:93–99.
   PubMedGoogle Scholar
• Hamai Y, Fujii T, Miki A, Geraghty DE, Harada I, Takai Y, Kozuma S, Tsutsumi O, Taketani Y. Quantitative assessment of human leukocyte antigen-G protein in amniotic fluid by a double-determinant enzyme-linked immunosorbent assay using anti-human leukocyte antigen-G-specific antibody ‘87G’. Am J Reprod Immunol 1999;41:293–295.
   PubMedGoogle Scholar
• Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, Fabiani JN, Dausset J, Carosella ED, Carpentier A. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002;105:1949–1954.
   PubMed Web of Science ®Google Scholar
• Amiot L, Onno M, Drenou B, Monvoisin C, Fauchet R. HLA-G class I gene expression in normal and malignant hematopoietic cells. Hum Immunol 1998;59:524–528.
   PubMed Web of Science ®Google Scholar
• Onno M, Pangault C, Le FG, Guilloux V, Andre P, Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000;164:6426–6434.
   PubMedGoogle Scholar
• Carosella ED, Moreau P, Aractingi S, Rouas-Freiss N. HLA-G: a shield against inflammatory aggression. Trends Immunol 2001;22:553–555.
   PubMedGoogle Scholar
• Torres MI, Lopez Casado MA, Rios A. New aspects in celiac disease. World J Gastroenterol 2007;13:1156–1161.
   PubMed Web of Science ®Google Scholar
• Torres MI, Le DM, Lorite P, Rios A, Gassull MA, Gil A, Maldonado J, Dausset J, Carosella ED. Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease. Int Immunol 2004;16:579–583.
   PubMed Web of Science ®Google Scholar
• Rizzo R, Melchiorri L, Simone L, Stignani M, Marzola A, Gullini S, Baricordi OR. Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease: a noninvasive diagnostic tool? Inflamm Bowel Dis 2008;14:100–105.
   PubMedGoogle Scholar
• Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. J Neuroimmunol 2005;159:155–164.
   PubMedGoogle Scholar
• Fainardi E, Rizzo R, Melchiorri L, Castellazzi M, Paolino E, Tola MR, Granieri E, Baricordi OR. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis. Mult Scler 2006;12:2–12.
   PubMedGoogle Scholar
• Airas L, Nikula T, Huang YH, Lahesmaa R, Wiendl H. Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G. J Neuroimmunol 2007;187:205–211.
   PubMed Web of Science ®Google Scholar
• Rizzo R, Mapp CE, Melchiorri L, Maestrelli P, Visentin A, Ferretti S, Bononi I, Miotto D, Baricordi OR. Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma. J Allergy Clin Immunol 2005;115:508–513.
   PubMedGoogle Scholar
• Nicolae D, Cox NJ, Lester LA, Schneider D, Tan Z, Billstrand C, Kuldanek S, Donfack J, Kogut P, Patel NM, et al Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 2005;76:349–357.
   PubMed Web of Science ®Google Scholar
• Ober C. HLA-G: an asthma gene on chromosome 6p. Immunol Allergy Clin North Am 2005;25:669–679.
   PubMedGoogle Scholar
• Verbruggen LA, Rebmann V, Demanet C, De CS, Grosse-Wilde H. Soluble HLA-G in rheumatoid arthritis. Hum Immunol 2006;67:561–567.
   PubMedGoogle Scholar
• Wiendl H, Behrens L, Maier S, Johnson MA, Weiss EH, Hohlfeld R. Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G. Ann Neurol 2000;48:679–684.
   PubMedGoogle Scholar
• Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Weiss EH, Dichgans J, Lochmuller H, Hohlfeld R, Melms A, Weller M. The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy. Brain 2003;126:176–185.
   PubMed Web of Science ®Google Scholar
• McIntire RH, Morales PJ, Petroff MG, Colonna M, Hunt JS. Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1. J Leukoc Biol 2004;76:1220–1228.
   PubMedGoogle Scholar
• McIntire, Hunt JS. Antigen presenting cells and HLA-G – a review. Placenta 2005;26(Suppl A):S104–S109.
   Google Scholar
• Moreau P, drian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, Carosella ED, Paul P. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999;11:803–811.
   PubMed Web of Science ®Google Scholar
• Gotsch F, Romero R, Kusanovic JP, Erez O, Espinoza J, Kim CJ, Vaisbuch E, Than NG, Mazaki-Tovi S, Chaiworapongsa T, et al The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10. J Matern Fetal Neonatal Med 2008;21:529–547.
   PubMed Web of Science ®Google Scholar
• Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 2000;101:191–200.
   PubMed Web of Science ®Google Scholar
• Kanai T, Fujii T, Unno N, Yamashita T, Hyodo H, Miki A, Hamai Y, Kozuma S, Taketani Y. Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood. Am J Reprod Immunol 2001;45:94–99.
   PubMed Web of Science ®Google Scholar